Have a question about our services? Click here to book a complimentary 10-minute call with Ryan, Aaron, Brennan or one of our staff. We will answer your questions and see what services may be right for you.
We provide serious investors with specific BUY/SELL/HOLD advice on undervalued micro, small, and mid-cap growth and value stocks. We dig deeper and search further into areas where traditional big bank or large institutional research will not look, providing you with independent first coverage of the fastest growing small-cap stocks.
KeyStone’s Income/Growth Stock Research Service provides retail and professional investors with independent BUY/SELL advice on Canada’s top Dividend Growth Stocks. By subscribing to KeyStone’s Income/Growth Stock Research Service you can start building your income/growth producing portfolio immediately, or re-tool a portfolio you already have.
Our USGS Research is designed to help you prudently and systematically build and develop your growth stock portfolio over a 6-month to 3-year period and help you beat the market long term. We believe in a patient approach that involves time-tested fundamental research in the under-researched area of the market – Small-Cap Growth & Value stocks.
Our Simple TFSA service combines our track record with easy-to-understand and actionable portfolio management advice. We take our “top stocks” from both our Small-Cap and Income Stock research to create a manageable 6 to 10 stock portfolio consisting of a diversified mix of high-growth small caps and dividend growth stocks.
In the world of stock markets dominated by large banks and investment companies, KeyStone’s independent Research Services offer a unique and completely independent perspective designed to help savvy investors make informed portfolio decisions.
Diversified Dividend Growth Stock Continues to Provide Attractive Opportunity For Long-Term Investors
Emerging Health-Tech Micro-Cap Posts Record Revenues, Seasonality, Reclassification & Start-Up Costs Affect Margins, Funding Secured – Expect 1-4 Accretive Acquisitions, MaRgins Normalize – Maintain SPEC BUY
Cash Producing Craft Cannabis Micro-Cap Interrupts Growth Path with Unexpectedly Weak Q2, Facility B Delays, & Move to Retail, Long-Term Growth Potential Remains – Shift to HOLD Near-Term
MoneyTalks Listeners – click here to book a complimentary 10-minute call with Ryan, Aaron, Brennan or one of our staff. We will answer your questions and see what services may be right for you.
